| Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 H Chen, RJ Lin, RL Schiltz, D Chakravarti, A Nash, L Nagy, ML Privalsky, ... Cell 90 (3), 569-580, 1997 | 1898 | 1997 |
| Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase L Nagy, HY Kao, D Chakravarti, RJ Lin, CA Hassig, DE Ayer, ... Cell 89 (3), 373-380, 1997 | 1656 | 1997 |
| Role of the histone deacetylase complex in acute promyelocytic leukaemia RJ Lin, L Nagy, S Inoue, W Shao, WH Miller Jr, RM Evans Nature 391 (6669), 811-814, 1998 | 1436 | 1998 |
| Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase H Chen, RJ Lin, W Xie, D Wilpitz, RM Evans Cell 98 (5), 675-686, 1999 | 844 | 1999 |
| Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation JU Peled, ALC Gomes, SM Devlin, ER Littmann, Y Taur, AD Sung, ... New England Journal of Medicine 382 (9), 822-834, 2020 | 600 | 2020 |
| Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein P Dhordain, O Albagli, RJ Lin, S Ansieau, S Quief, A Leutz, JP Kerckaert, ... Proceedings of the National Academy of Sciences 94 (20), 10762-10767, 1997 | 413 | 1997 |
| The LAZ3 (BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression P Dhordain, S Quief, D Lantoine, JP Kerckaert, O Albagli, RJ Lin, ... Nucleic acids research 26 (20), 4645-4651, 1998 | 332 | 1998 |
| Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers RJ Lin, RM Evans Molecular cell 5 (5), 821-830, 2000 | 275 | 2000 |
| Transcriptional regulation in acute promyelocytic leukemia RJ Lin, T Sternsdorf, M Tini, RM Evans Oncogene 20 (49), 7204-7215, 2001 | 252 | 2001 |
| Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2 W Xie, H Hong, NN Yang, RJ Lin, CM Simon, MR Stallcup, RM Evans Molecular endocrinology 13 (12), 2151-2162, 1999 | 202 | 1999 |
| Paraneoplastic thrombocytosis: the secrets of tumor self-promotion RJ Lin, V Afshar-Kharghan, AI Schafer Blood, The Journal of the American Society of Hematology 124 (2), 184-187, 2014 | 195 | 2014 |
| Molecular genetics of acute promyelocytic leukemia RJ Lin, DA Egan, RM Evans Trends in Genetics 15 (5), 179-184, 1999 | 158 | 1999 |
| Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF E Feige, S Yokoyama, C Levy, M Khaled, V Igras, RJ Lin, S Lee, ... Proceedings of the National Academy of Sciences 108 (43), E924-E933, 2011 | 156 | 2011 |
| Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy R Shouval, A Alarcon Tomas, JA Fein, JR Flynn, E Markovits, S Mayer, ... Journal of clinical oncology 40 (4), 369-381, 2022 | 115 | 2022 |
| Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies D Sermer, C Batlevi, ML Palomba, G Shah, RJ Lin, MA Perales, M Scordo, ... Blood advances 4 (19), 4669-4678, 2020 | 108 | 2020 |
| CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results JH Park, K Nath, SM Devlin, CS Sauter, ML Palomba, G Shah, P Dahi, ... Nature medicine 29 (7), 1710-1717, 2023 | 94 | 2023 |
| Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies R Stuver, GL Shah, NS Korde, LE Roeker, AR Mato, CL Batlevi, DJ Chung, ... Cancer cell 40 (6), 590-591, 2022 | 94 | 2022 |
| Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP53 alterations RJ Lin, C Ho, PD Hilden, JN Barker, SA Giralt, PA Hamlin, AA Jakubowski, ... British journal of haematology 184 (6), 1006-1010, 2019 | 75 | 2019 |
| Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes RL Olin, C Fretham, MC Pasquini, M Arora, VR Bhatt, B Derman, SA Giralt, ... Blood advances 4 (12), 2810-2820, 2020 | 62 | 2020 |
| Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma A Alarcon Tomas, JA Fein, S Fried, JR Flynn, SM Devlin, WB Fingrut, ... Leukemia 37 (1), 154-163, 2023 | 55 | 2023 |